In contrast to MS and AQP4-IgG seropositive NMOSD, the application of gadolinium rarely reveals a lesion enhancement pattern in MOGAD but can lead to unspecific leptomeningeal enhancement around the brainstem or in uni- or bilateral cortical areas, especially in MOGAD with cortical encephalitis. The gene discussed is AQP4; the disease is myeloid sarcoma.